NEUROCRINE BIOSCIENCES INC - COM (NBIX)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
93.7M
Holdings value Q2 2024
$12.9B
Value change Q2 2024
+$107M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
581
Number of buys Q2 2024
59
Number of sells Q2 2024
-71
Average buys Q2 2024 %
+0.003%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.41M $393M -$1.77M $115.22 127
2024 Q2 93.7M $12.9B +$107M $137.67 585
2024 Q1 92.8M $12.8B +$62.8M $137.92 576
2023 Q4 91.7M $12.1B +$37.3M $131.76 538
2023 Q3 91.1M $10.3B +$10.9M $112.50 501
2023 Q2 91.3M $8.61B +$32.2M $94.30 446
2023 Q1 90.7M $9.18B +$66.8M $101.22 475
2022 Q4 89.8M $10.7B +$105M $119.44 520
2022 Q3 90.2M $9.58B -$38M $106.21 446
2022 Q2 89.5M $8.72B -$28M $97.48 425
2022 Q1 89.9M $8.43B +$138M $93.75 414
2021 Q4 89.1M $7.58B -$143M $85.17 389
2021 Q3 90.2M $8.65B -$95.6M $95.91 386
2021 Q2 91.3M $8.88B -$379M $97.32 394
2021 Q1 95M $9.24B +$548M $97.25 406
2020 Q4 89.4M $8.57B -$28.1M $95.85 392
2020 Q3 89.6M $8.62B -$169M $96.16 405
2020 Q2 91M $11.1B +$58.3M $122.00 410
2020 Q1 90.4M $7.83B +$141M $86.55 358
2019 Q4 88.8M $9.55B -$106M $107.49 384
2019 Q3 89.6M $8.08B +$133M $90.11 327
2019 Q2 88.9M $7.5B +$405M $84.43 302
2019 Q1 88.3M $7.78B -$72.3M $88.10 328
2018 Q4 89.5M $6.37B -$95.1M $71.41 321
2018 Q3 88.6M $10.9B -$351M $122.95 341
2018 Q2 91.9M $9.03B +$3.59M $98.24 275
2018 Q1 92M $7.63B -$147M $82.93 265
2017 Q4 93.8M $7.28B -$129M $77.59 260
2017 Q3 96M $5.88B +$104M $61.28 219
2017 Q2 94.9M $4.36B +$661M $46.00 219
2017 Q1 85.1M $3.68B +$239M $43.30 216
2016 Q4 84.4M $3.27B -$80.4M $38.70 221
2016 Q3 85.7M $4.34B +$54.5M $50.64 239
2016 Q2 84.8M $3.86B -$118M $45.45 226
2016 Q1 87.6M $3.46B +$139M $39.55 209
2015 Q4 83.4M $4.72B +$51.6M $56.57 217
2015 Q3 82.8M $3.29B -$27.2M $39.79 204
2015 Q2 83.2M $3.97B -$85.1M $47.76 195
2015 Q1 85.2M $3.38B +$406M $39.71 172
2014 Q4 75.2M $1.68B +$53.1M $22.34 132
2014 Q3 73.3M $1.15B +$43.8M $15.67 132
2014 Q2 70.4M $1.05B +$8.29M $14.84 124
2014 Q1 69.8M $1.12B +$195M $16.10 122